NV

npj Vaccines

npj Vaccines is part of the npj Series and is published in partnership with the University of Texas Medical Branch. It publishes vaccine research and reports a 2-year impact factor of 6.6 (2024), 3,901,115 article downloads in 2025, and 13 days from submission to first editorial decision (2025).

Looking to publish in npj Vaccines? Livewrite integrates seamlessly with Word to help you write, edit, and format faster.

Try Livewrite Now
Subject Immunology, Medicine, Research & Experimental
Impact Factor 6.5
Quartile Q1
Open Access Type Open
eISSN 2059-0105
Invitation Only No
Cost Range Article processing charge (APC) applies; current APCs and waiver information are available via the APC section.

Submission Instructions

npj Vaccines accepts the following article types. Click on an article type to view submission instructions.

Article

Cover Letter Cover letter must accompany the submission.
Abstract Abstract is required. Abstract must be no more than 150 words. Abstract must be unstructured with no subheadings.
Manuscript Manuscript must include an Introduction with no subheadings, Results with subheadings, Discussion with no subheadings and no limitations or conclusions section, and Methods with subheadings, with all Methods content included in the main manuscript file. Manuscript must include a Data availability section, an Author contributions statement naming all authors by initials, a Competing Interests statement, and funding information in the Acknowledgments rather than in a separate Funding statement.
References References are limited to 60, though this limit is not strictly enforced.
Figures & Tables Figure legends must be no more than 350 words per figure, and multi-panel figures must appear on a single page with panels labeled a), b), c), and so on.
Reformat to npj Vaccines using Livewrite Premium

Review

Cover Letter A cover letter must accompany the submission.
Abstract Abstract must be no more than 70 words. Abstract must be unstructured with no subheadings.
Manuscript Main text is typically 3,000–4,000 words in length. Main text may include subheadings. The manuscript must include an Author contributions statement identifying each author by initials and a Competing Interests statement declaring financial and non-financial competing interests or stating that none exist.
References References are limited to 60, though this limit is not strictly enforced.
Figures & Tables Figure legends must be no more than 350 words per figure, and multi-panel figures must appear on a single page with panels labeled a), b), c), and so on.
Reformat to npj Vaccines using Livewrite Premium

Brief Communication

Cover Letter A cover letter must accompany the submission.
Abstract An abstract is required. Abstract must be no more than 70 words. Abstract must be unstructured with no subheadings.
Manuscript Main text should be 1,000-1,500 words, excluding the abstract, methods, references, and figure legends. Main text must have no subheadings, while the Methods section must use subheadings. The manuscript must include an Author contributions statement naming all authors by initials, a Competing Interests statement for each author, and a Code availability section where applicable.
References References should be around 20.
Figures & Tables Methods descriptions must be included in the main manuscript file rather than in the Supplementary Information. Figure legends must be limited to 350 words per figure, and multi-panel figures must appear on a single page with panels labeled a), b), c), and so on.
Reformat to npj Vaccines using Livewrite Premium

Case Report

Cover Letter Cover letter must accompany the submission.
Abstract Abstract must be no longer than 150 words. Abstract must be unstructured with no subheadings.
Manuscript Manuscript must include Methods, Results, and Discussion sections, with subheadings required in Methods and Results and prohibited in Discussion. Manuscript must include a mandatory Author contributions statement identifying each author by initials, a mandatory Competing Interests statement for each author, and a mandatory Data availability section, with a Code availability section included where applicable.
References References should be around 50 as a guide.
Figures & Tables Multi-panel figures must be presented on a single page with panels labeled a), b), c), and figure legends must not exceed 350 words per figure.
Reformat to npj Vaccines using Livewrite Premium

Recent Publications

Chitosan nanoparticles for mucosal and needle-free vaccination

Changchun Chen, Cheng Zhang, Shanyuan Zhu, Shinuo Cao

10.1038/s41541-026-01496-8
View Publication

Schistosomiasis vaccine SchistoShield® induces functional immune memory responses in US and African populations

Mumtaz Y. Balkhi, Aravindan Kalyanasundaram, Aryandra Arya, Desalegn W. Kifle, Mallory Mckinnon, Dinesh Krishnappa, Harshvardhan Shrivastava, Mohamadou Siribie, Asma Aziz, Hyonjin Jeon, Tanyada Yongchaitrakul, Birkneh T. Tadesse, Njariharinjakamampionona Rakotozandrindrainy, Ravomialisoa Razafimanantsoa, Henry Bere Noellie, Nebié Issa Ouedraogo, Amidou Diarra, Sean A. Gray, Rhea N. Coler, Jinhee Lee, Raphaël Rakotozandrindrainy, Sodiomon B. Sirima, Lisa A. Jackson, Florian Marks, Darrick Carter, Afzal A. Siddiqui

10.1038/s41541-026-01501-0
View Publication

Author Correction: Production of an immunogenic trivalent poliovirus virus-like particle vaccine candidate in yeast using controlled fermentation

Lee Sherry, Keith Grehan, Mohammad W. Bahar, Jessica J. Swanson, Helen Fox, Sue Matthews, Sarah Carlyle, Ling Qin, Claudine Porta, Steven Wilkinson, Suzanne Robb, Naomi Clark, John Liddell, Elizabeth E. Fry, David I. Stuart, Andrew J. Macadam, David J. Rowlands, Nicola J. Stonehouse

10.1038/s41541-026-01470-4
View Publication

MVA-BN monkeypox vaccine safety in a clinical trial in the Democratic Republic of the Congo

Nsengi Ntamabyaliro, Tyler Bonnett, Gail Potter, Emily Yox, Laurens Liesenborghs, Olivier Tshiani Mbaya, Veronique Nussenblatt, Tarcisse Kapene Kilara, Aline Biongo Engo, Emmanuella Muhima, Percy Velela, Laetitia Itunime, Jean-Luc Biampata, Placide Mbala, Mariano Lusakibanza, Michael Kombozi Basika, Gaston Tona, Susan Vogel, H. Clifford Lane, Lori E. Dodd, Jean-Jaques Muyembe

10.1038/s41541-026-01490-0
View Publication

Trends in funding for coronavirus vaccine research and development: implications for preparedness against future coronavirus threats

Derek Fleming, Emily Smith, Julie Ostrowsky, Angela Ulrich, Tabitha Leighton, Natalie Vestin, Angela J. Mehr, Rodrigo Furst, Alice Norton, Eve Lackritz

10.1038/s41541-026-01493-x
View Publication

Frequently asked questions

How long does it take to publish?

13 days from submission to first editorial decision (2025).

Reformat to npj Vaccines using Livewrite Premium

Is a cover letter required?

A cover letter is required for all submissions.

Reformat to npj Vaccines using Livewrite Premium

What are the publication costs?

Research Topics

SARS-CoV-2 and COVID-19 Research Immunotherapy and Immune Responses Influenza Virus Research Studies Mosquito-borne diseases and control Viral gastroenteritis research and epidemiology Respiratory viral infections research Viral Infections and Vectors vaccines and immunoinformatics approaches Animal Virus Infections Studies Viral Infections and Outbreaks Research Malaria Research and Control COVID-19 Clinical Research Studies Vaccine Coverage and Hesitancy HIV Research and Treatment Virology and Viral Diseases Immune Response and Inflammation Viral Infections and Immunology Research Immune responses and vaccinations RNA Interference and Gene Delivery Herpesvirus Infections and Treatments Pneumonia and Respiratory Infections Bacterial Infections and Vaccines Monoclonal and Polyclonal Antibodies Research Immune Cell Function and Interaction T-cell and B-cell Immunology

Related Journals

NR
Nature Reviews Clinical Oncology NATURE PORTFOLIO
AR
Aids Reviews PERMANYER PUBL
BB
Brain Behavior & Immunity - Health Elsevier BV
JO
Journal of Translational Medicine BioMed Central
TJ
The Journal of Allergy and Clinical Immunology In Practice Elsevier BV
BJ
Biomedical Journal Elsevier BV